Case Commentary: “Salvage Treatment of Refractory HSV Oral Lesions with Pritelivir in Allogeneic Hematopoietic Cell Transplant Recipients” by Bosetti et al.
Antimicrobial Agents and Chemotherapy · 2023
DOI: 10.1128/aac.00276-23 ↗Kurz gefasst
Kommentar in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2023. Verfasst von Krithika Srinivasan und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases & Geographic Medicine, School of Medicine, Stanford University, Stanford, California, USA. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation, Herpes Simplex. Die Arbeit nennt 6 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Infectious Diseases & Geographic Medicine, School of Medicine, Stanford University, Stanford, California, USA.
Zitieren
APA
Srinivasan, K., & Ho, D. Y. (2023). Case Commentary: “Salvage Treatment of Refractory HSV Oral Lesions with Pritelivir in Allogeneic Hematopoietic Cell Transplant Recipients” by Bosetti et al. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.00276-23
Vancouver
Srinivasan K, Ho DY. Case Commentary: “Salvage Treatment of Refractory HSV Oral Lesions with Pritelivir in Allogeneic Hematopoietic Cell Transplant Recipients” by Bosetti et al. Antimicrobial Agents and Chemotherapy. 2023. doi:10.1128/aac.00276-23
BibTeX
@article{Srinivasan2023,
author = {Srinivasan, Krithika and Ho, Dora Y},
title = {Case Commentary: “Salvage Treatment of Refractory HSV Oral Lesions with Pritelivir in Allogeneic Hematopoietic Cell Transplant Recipients” by Bosetti et al},
journal = {Antimicrobial Agents and Chemotherapy},
year = {2023},
doi = {10.1128/aac.00276-23}
}
EUVIMED